Call us now:
The framework for establishing a biotech company in Thailand
Thailand is rapidly cultivating a strategic position for biotechnology across Southeast Asia, powered by robust governmental encouragement, beneficial investment motives, and a maturing regulatory landscape. Venturers aiming to initiate a biotech company in Thailand will discover a legal framework that inspires progress while sustaining regulatory adherence and international investment oversight.
Central to the lawful arrangement is the Foreign Business Act B.E. 2542 (1999), which usually restricts foreigners from participating in specified sectors unless they obtain a Foreign Business License (FBL) or benefit from promotional privileges granted by the Thailand Board of Investment. Thankfully, biotech-related activities are among those that qualify for BOI sponsorship under certain classifications, allowing foreign investors to operate with up to 100% ownership and receive a suite of incentives such as corporate earnings tax exemptions, import tariff waivers, and facilitated visa and work permit procedures.
The Investment Promotion Act B.E. 2520 (1977), administered by the BOI, encourages the development of advanced technologies, including bioplastics, biochemicals, and biotechnology R&D. Companies under BOI categories 1.5.1, 1.5.2, or 1.6 may obtain significant fiscal incentives if they meet requirements on capital investment, local employment, and innovation.
Thailand’s legal framework is supported by strategic policies such as Thailand 4.0 and the National Biotechnology Policy Framework, which identify biotech as a key driver of sustainable and high-value growth. Leading institutions such as TCELS and NSTDA strengthen the national R&D ecosystem and promote research partnerships.
At Benoit & Partners, we guide investors entering Thailand’s biotechnology sector. A clear understanding of regulations, eligibility criteria, and available incentives is essential in this regulated field. Our team advises on compliance, licensing, and BOI promotion benefits to structure investments efficiently while ensuring full adherence to Thai law.
Get expert legal guidance.
Table of Contents
Benefits of establishing a biotech company in Thailand
Beyond its legal framework, Thailand attracts investors who want to establish a biotech company.
The government provides strong support and develops a skilled workforce integrated into global supply chains. Under the Thailand 4.0 model, policymakers place biotech at the center of an innovation-driven economy. BOI incentives and the National Biotechnology Policy Framework encourage foreign projects in agriculture, pharmaceuticals, and green technologies.
Thailand also hosts a growing network of research organizations that create public-private partnerships and grant programs. The Thailand Center of Excellence for Life Sciences and the National Science and Technology Development Agency support biotech innovation.
Companies gain access to raw materials, affordable skilled talent, and regional trade agreements.
These factors make Thailand attractive for establishing and expanding biotech operations across Southeast Asia.
Legal structure suitable for a biotech company in Thailand
When incorporating a biotech company in Thailand, carefully selecting the proper legal structure is key to ensure regulatory adherence and BOI incentive eligibility. Foreign investors commonly opt for a Thai limited company thanks to its flexibility and compatibility with BOI schemes.
A limited company requires at least three shareholders and may operate as wholly foreign-owned or majority Thai-owned, depending on the industry and the Foreign Business Act rules. If the company plans activities under List 2 or 3, it must obtain a Foreign Business License unless it qualifies for BOI promotion.
For biotech company in Thailand, investors often pursue BOI promotion to secure exemptions on foreign ownership limits, import duties, and corporate income tax. The company must submit a detailed proposal to the BOI that describes biotech activities, investment value, technology use, and projected economic impact.
After incorporation, the company must comply with Thai labor, tax, and accounting laws. Companies that conduct biotech research or production must obtain licenses from authorities such as the Food and Drug Administration, the Ministry of Public Health, or the National Science and Technology Development Agency, depending on their activities.
Get expert legal guidance.
Overview of BOI-promoted Categories for biotech companies in Thailand
The BOI provides specific categories that support biotech company in Thailand growth and expansion. These activity categories link fiscal and non-fiscal incentives to a project’s scale and national contribution. The following sections examine key BOI categories and outline their conditions and benefits.
Manufacture of bioplastic or products from bioplastic
This BOI category supports biotech company in Thailand producing bioplastic materials or related products. Projects under this category receive tax incentives and reflect the government’s commitment to a circular bioeconomy.
This category grants eligibility under the A2 or A3 incentive group, depending on the project and compliance with standards. Companies that manufacture bioplastics through a continuous certified process within one project may receive an eight-year corporate income tax exemption under A2. Authorities also grant import duty exemptions on machinery and raw materials. Companies that manufacture products from bioplastics through plastic forming and certified bio-based content may qualify under A3. This category grants a five-year corporate income tax exemption. Companies must obtain certification before starting full operations.
The biotech company in Thailand must use environmentally sustainable production methods aligned with international standards. The company must obtain certifications confirming bio-based content and degradability. These projects support innovation, sustainability, and circular raw material use under the Bio-Circular-Green model.
Manufacture of biochemicals
This category supports biotech company in Thailand producing biochemicals from biomass, agricultural waste, or agricultural byproducts. The BOI promotes this sector to reduce reliance on petrochemicals and develop green industries.
The company must ensure that at least 51% of total input weight comes from agricultural sources. Eligible materials include biomass and agricultural byproducts. The BOI excludes projects that involve only blending or dilution processes.
To meet requirements, the biotech company in Thailand must obtain international biodegradability certification. Acceptable certifications include those under the OECD Guidelines for the Testing of Chemicals, such as Test No. 301. The company must secure certification before starting operations.
Projects that meet these conditions may obtain BOI promotion under category A2. This category grants an eight-year corporate income tax exemption and import duty exemptions on machinery. These incentives support companies during scale-up and commercialization phases.
Thailand promotes biochemical development due to its natural resources and environmental objectives. Biotech companies in this field contribute to the bioeconomy through green chemicals, biofuels, and biomaterials.
Biotechnology development
This BOI category targets research-driven biotech company in Thailand developing new technologies for healthcare, agriculture, or environmental sectors. Projects under this category may qualify for A1+ incentives.
The A1+ category grants a ten-year corporate income tax exemption without a cap. This structure benefits startups and R&D centers focused on long-term innovation. Authorities also grant visa and work permit facilitation for foreign experts. Companies may receive import duty exemptions on research equipment.
To qualify, the biotech company in Thailand must conduct technology development that supports BOI-targeted industries. The BOI requires formal collaboration with Thai academic institutions for technology transfer. Acceptable cooperation includes joint research, academic partnerships, or structured training programs.
A strong application must describe research protocols, objectives, and measurable outcomes in detail. The proposal must show how the project strengthens Thailand’s biomanufacturing capacity and industrial skills. The BOI assesses whether the initiative enhances national self-sufficiency and global competitiveness through science.
Conclusion
In summary, starting a biotech company in Thailand offers significant advantages. Investors benefit from favorable policies, strategic location, skilled labor, and state-backed innovation support. Most investors choose a Thai limited company to access BOI incentives and ensure regulatory compliance.
The BOI promotes biotech investment through three main categories: biochemical manufacture, bioplastic production, and biotechnology development. Each category provides specific fiscal and non-fiscal incentives based on technical criteria and compliance with international standards.
Foreign investors who plan to establish or expand a biotech company in Thailand should seek qualified legal advice. Advisors help navigate the BOI process, confirm eligibility, and secure required licenses. With careful planning and a clear understanding of the BOI framework, Thailand offers strong potential for biotechnology innovation.
If you need further information, you may schedule an appointment with one of our lawyers.
FAQ
Thailand offers strong government support, BOI incentives, skilled labor, and access to regional markets under the Thailand 4.0 and BCG (Bio-Circular-Green) models.
Most foreign investors choose a Thai limited company, which is compatible with BOI promotion and can allow full foreign ownership if incentives are granted.
Eligible companies may receive corporate income tax exemptions (5–10 years), import duty exemptions, foreign ownership rights, and visa/work permit facilitation for experts.
Depending on activities, approvals may be needed from the Food and Drug Administration (FDA), the Ministry of Public Health, or the National Science and Technology Development Agency (NSTDA
Yes, if BOI promotion is granted. Without BOI approval, foreign ownership is restricted under the Foreign Business Act unless a Foreign Business License is obtained.